Skip to main content

Advertisement

SpringerLink
Log in

Overexpression of glutathione peroxidase 1 predicts poor prognosis in oral squamous cell carcinoma

  • Original Article – Clinical Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Intracellular antioxidant enzymes are commonly upregulated in various cancer types and are associated with treatment outcomes. Because the relationship has rarely been examined in oral squamous cell carcinoma (OSCC), we aimed to evaluate the association between the levels of glutathione peroxidase (GPX)1, GPX4, and thioredoxin reductase (TrxR)1 expression and prognosis in patients with OSCC who underwent curative surgical resection.

Methods

This study included 233 patients who underwent curative surgery for previously untreated OSCC between 2000 and 2012. Tumour GPX1, GPX4, and TrxR1 expression was evaluated by immunohistochemistry and was dichotomised to low and high values according to defined expression levels. The association between GPX1, GPX4, and TrxR1 expression and clinicopathological results was analysed. Univariate and multivariate analyses using the Cox proportional hazards model were conducted to assess the significance of differences in recurrence or survival outcomes between variables.

Results

High GPX1, GPX4, and TrxR1 expression was observed in 99 (42.5%), 133 (57.1%), and 46 (19.7%) patients, respectively. GPX1 overexpression was significantly correlated with nodal metastasis, advanced overall stage, depth of invasion of >10 mm, high grade and perineural invasion (P < 0.05). High GPX4 expression was also related to nodal metastasis, overall advanced stage and high grade (P < 0.05). Univariate and multivariate analyses showed that increased GPX1 expression was significantly associated with poor disease-free, cancer-specific and overall survival (all P < 0.05), while increased GPX4 or TrxR1 expression was not (all P > 0.1).

Conclusions

Tumour GPX1 expression is a useful biomarker predictive of recurrence and survival in OSCC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Abourashed EA (2013) Bioavailability of plant-derived antioxidants. Antioxidants (Basel) 2(4):309–325

    Article  Google Scholar 

  • Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Neugut AI, Ambrosone CB (2005) No association between glutathione peroxidase Pro198Leu polymorphism and breast cancer risk. Cancer Epidemiol Biomark Prev 14(10):2459–2461

    Article  CAS  Google Scholar 

  • Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4(6):807–818

    Article  CAS  PubMed  Google Scholar 

  • Arthur JR (2000) The glutathione peroxidases. Cell Mol Life Sci 57(13–14):1825–1835

    CAS  PubMed  Google Scholar 

  • Cairns RA, Harris IS, Mak TW (2011) Regulation of cancer cell metabolism. Nat Rev Cancer 11(2):85–95

    Article  CAS  PubMed  Google Scholar 

  • Cebrian A, Pharoah PD, Ahmed S, Smith PL, Luccarini C, Luben R, Redman K, Munday H, Easton DF, Dunning AM, Ponder BA (2006) Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer. Cancer Res 66(2):1225–1233

    Article  CAS  PubMed  Google Scholar 

  • Cherubini A, Beal MF, Frei B (1999) Black tea increases the resistance of human plasma to lipid peroxidation in vitro, but not ex vivo. Free Radic Biol Med 27(3–4):381–387

    Article  CAS  PubMed  Google Scholar 

  • Corti A, Franzini M, Paolicchi A, Pompella A (2010) Gamma-glutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting. Anticancer Res 30(4):1169–1181

    CAS  PubMed  Google Scholar 

  • Cox DG, Hankinson SE, Kraft P, Hunter DJ (2004) No association between GPX1 Pro198Leu and breast cancer risk. Cancer Epidemiol Biomark Prev 13(11 Pt 1):1821–1822

    CAS  Google Scholar 

  • Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, Garberoglio C, Paz B, Shen J, Lau SK, Quake SR, Brown JM, Weissman IL, Clarke MF (2009) Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458(7239):780–783

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Eriksson SE, Prast-Nielsen S, Flaberg E, Szekely L, Arner ES (2009) High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy. Free Radic Biol Med 47(11):1661–1671

    Article  CAS  PubMed  Google Scholar 

  • Fasanaro E, Staffieri C, Cappellesso R, Marino F, Ottaviano G, Val M, Giacomelli L, de Filippis C, Stellini E, Staffieri A, Marioni G (2015) Prognostic significance of serine-phosphorylated STAT3 expression in pT1–T2 oral tongue carcinoma. Clin Exp Otorhinolaryngol 8(3):275–280

    Article  PubMed  PubMed Central  Google Scholar 

  • Filaire E, Dupuis C, Galvaing G, Aubreton S, Laurent H, Richard R, Filaire M (2013) Lung cancer: what are the links with oxidative stress, physical activity and nutrition. Lung Cancer 82(3):383–389

    Article  PubMed  Google Scholar 

  • Fu TY, Hou YY, Chu ST, Liu CF, Huang CH, Chen HC, Hsiao M, Lu PJ, Wang JS, Ger LP (2011) Manganese superoxide dismutase and glutathione peroxidase as prognostic markers in patients with buccal mucosal squamous cell carcinomas. Head Neck 33(11):1606–1615

    Article  PubMed  Google Scholar 

  • Gan X, Chen B, Shen Z, Liu Y, Li H, Xie X, Xu X, Li H, Huang Z, Chen J (2014) High GPX1 expression promotes esophageal squamous cell carcinoma invasion, migration, proliferation and cisplatin-resistance but can be reduced by vitamin D. Int J Clin Exp Med 7(9):2530–2540

    CAS  PubMed  PubMed Central  Google Scholar 

  • Geweiler J, Inhestern J, Berndt A, Guntinas-Lichius O (2016) Parameters of stromal activation and epithelial to mesenchymal transition as predictive biomarkers for induction chemotherapy in patients with locally advanced oral cavity and oropharyngeal squamous cell cancer. Clin Exp Otorhinolaryngol 9(4):374–381

    Article  PubMed  PubMed Central  Google Scholar 

  • Guerriero E, Capone F, Accardo M, Sorice A, Costantini M, Colonna G, Castello G, Costantini S (2015) GPX4 and GPX7 over-expression in human hepatocellular carcinoma tissues. Eur J Histochem 59(4):2540

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Heinonen OP, Albanes D (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 330(15):1029–1035

    Article  Google Scholar 

  • Hu YJ, Diamond AM (2003) Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res 63(12):3347–3351

    CAS  PubMed  Google Scholar 

  • Iwasawa S, Yamano Y, Takiguchi Y, Tanzawa H, Tatsumi K, Uzawa K (2011) Upregulation of thioredoxin reductase 1 in human oral squamous cell carcinoma. Oncol Rep 25(3):637–644

    CAS  PubMed  Google Scholar 

  • Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL Jr, Baker LH (2011) Vitamin E and the risk of prostate cancer: the selenium and Vitamin E cancer prevention trial (SELECT). JAMA 306(14):1549–1556

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Knight JA, Onay UV, Wells S, Li H, Shi EJ, Andrulis IL, Ozcelik H (2004) Genetic variants of GPX1 and SOD2 and breast cancer risk at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiol Biomark Prev 13(1):146–149

    Article  CAS  Google Scholar 

  • Lisboa da Motta L, Muller CB, De Bastiani MA, Behr GA, Franca FS, da Rocha RF, Minotto JB, Meurer RT, Fernandes MC, Roehe A, Markoski MM, Andrade CF, Castro MA, Klamt F (2014) Imbalance in redox status is associated with tumor aggressiveness and poor outcome in lung adenocarcinoma patients. J Cancer Res Clin Oncol 140(3):461–470

    Article  CAS  PubMed  Google Scholar 

  • Min SY, Kim HS, Jung EJ, Jung EJ, Jee CD, Kim WH (2012) Prognostic significance of glutathione peroxidase 1 (GPX1) down-regulation and correlation with aberrant promoter methylation in human gastric cancer. Anticancer Res 32(8):3169–3175

    CAS  PubMed  Google Scholar 

  • Mochizuki T, Furuta S, Mitsushita J, Shang WH, Ito M, Yokoo Y, Yamaura M, Ishizone S, Nakayama J, Konagai A, Hirose K, Kiyosawa K, Kamata T (2006) Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells. Oncogene 25(26):3699–3707

    Article  CAS  PubMed  Google Scholar 

  • Nalkiran I, Turan S, Arikan S, Kahraman OT, Acar L, Yaylim I, Ergen A (2015) Determination of gene expression and serum levels of MnSOD and GPX1 in colorectal cancer. Anticancer Res 35(1):255–259

    CAS  PubMed  Google Scholar 

  • Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334(18):1150–1155

    Article  CAS  PubMed  Google Scholar 

  • Rabik CA, Dolan ME (2007) Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 33(1):9–23

    Article  CAS  PubMed  Google Scholar 

  • Ravn-Haren G, Olsen A, Tjonneland A, Dragsted LO, Nexo BA, Wallin H, Overvad K, Raaschou-Nielsen O, Vogel U (2006) Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis 27(4):820–825

    Article  CAS  PubMed  Google Scholar 

  • Schafer ZT, Grassian AR, Song L, Jiang Z, Gerhart-Hines Z, Irie HY, Gao S, Puigserver P, Brugge JS (2009) Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 461(7260):109–113

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Spitz DR, Phillips JW, Adams DT, Sherman CM, Deen DF, Li GC (1993) Cellular resistance to oxidative stress is accompanied by resistance to cisplatin: the significance of increased catalase activity and total glutathione in hydrogen peroxide-resistant fibroblasts. J Cell Physiol 156(1):72–79

    Article  CAS  PubMed  Google Scholar 

  • Sun S, Pan X, Zhao L, Zhou J, Wang H, Sun Y (2016) The expression and relationship of CD68-tumor-associated macrophages and microvascular density with the prognosis of patients with laryngeal squamous cell carcinoma. Clin Exp Otorhinolaryngol 9(3):270–277

    Article  PubMed  PubMed Central  Google Scholar 

  • Tafani M, Sansone L, Limana F, Arcangeli T, De Santis E, Polese M, Fini M, Russo MA (2016) The interplay of reactive oxygen species, hypoxia, inflammation, and sirtuins in cancer initiation and progression. Oxid Med Cell Longev 2016:3907147

    Article  PubMed  Google Scholar 

  • Teoh-Fitzgerald ML, Fitzgerald MP, Zhong W, Askeland RW, Domann FE (2014) Epigenetic reprogramming governs EcSOD expression during human mammary epithelial cell differentiation, tumorigenesis and metastasis. Oncogene 33(3):358–368

    Article  CAS  PubMed  Google Scholar 

  • Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H, Chiao PJ, Achanta G, Arlinghaus RB, Liu J, Huang P (2006) Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 10(3):241–252

    Article  CAS  PubMed  Google Scholar 

  • Wheaton WW, Weinberg SE, Hamanaka RB, Soberanes S, Sullivan LB, Anso E, Glasauer A, Dufour E, Mutlu GM, Budigner GS, Chandel NS (2014) Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis. Elife 3:e02242

    Article  PubMed  PubMed Central  Google Scholar 

  • Woolston CM, Madhusudan S, Soomro IN, Lobo DN, Reece-Smith AM, Parsons SL, Martin SG (2013) Thioredoxin interacting protein and its association with clinical outcome in gastro-oesophageal adenocarcinoma. Redox Biol 1:285–291

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yanagawa T, Omura K, Harada H, Ishii T, Uwayama J, Nakaso K, Iwasa S, Koyama Y, Onizawa K, Yusa H, Yoshida H (2005) Peroxiredoxin I expression in tongue squamous cell carcinomas as involved in tumor recurrence. Int J Oral Maxillofac Surg 34(8):915–920

    Article  CAS  PubMed  Google Scholar 

  • Zhang H, Liu X, Chen L, Cai L, Li N, Zhu P, Chen J, Song X, Li G (2017) Differential expression of peroxiredoxin 3 in laryngeal squamous cell carcinoma. Oncotarget 8(2):3471–3480

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otolaryngology, Asan Medical Centre, University of Ulsan College of Medicine, 88 Olympic-ro, 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea

    Jae Ryung Lee, Jong-Lyel Roh, Seung-Ho Choi, Soon Yuhl Nam & Sang Yoon Kim

  2. Department of Pathology, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, Republic of Korea

    Sun Mi Lee, Yangsoon Park & Kyung-Ja Cho

Authors
  1. Jae Ryung Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jong-Lyel Roh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sun Mi Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yangsoon Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kyung-Ja Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Seung-Ho Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Soon Yuhl Nam
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sang Yoon Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jong-Lyel Roh.

Ethics declarations

Funding

This study was supported by a Grant (no. 2015R1A2A1A15054540) from Basic Science Research Program through the National Research Foundation of Korea (NRF), Ministry of Science, ICT, and Future Planning, and a Grant (no. HI15C2920) from the Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), Ministry of Health & Welfare, Seoul, Republic of Korea (J.-L. Roh).

Conflict of interest

The authors have no conflict of interest to disclose.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research board and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, J.R., Roh, JL., Lee, S.M. et al. Overexpression of glutathione peroxidase 1 predicts poor prognosis in oral squamous cell carcinoma. J Cancer Res Clin Oncol 143, 2257–2265 (2017). https://doi.org/10.1007/s00432-017-2466-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-017-2466-7

Keywords

Search

Navigation